Approved Drug Products with Therapeutic Equivalence Evaluations, 1999 PDF Download

Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Approved Drug Products with Therapeutic Equivalence Evaluations, 1999 PDF full book. Access full book title Approved Drug Products with Therapeutic Equivalence Evaluations, 1999 by Barry Leonard. Download full books in PDF and EPUB format.

Approved Drug Products with Therapeutic Equivalence Evaluations, 1999

Approved Drug Products with Therapeutic Equivalence Evaluations, 1999 PDF Author: Barry Leonard
Publisher: DIANE Publishing
ISBN: 0788186795
Category :
Languages : en
Pages : 892

Book Description
Identifies drug products approved on the basis of safety & effectiveness by the FDA under the Federal Food, Drug, & Cosmetic Act. Drugs on the market approved only on the basis of safety (covered by the ongoing Drug Efficacy Study Implementation review) or pre-1938 drugs are not included in this publication. The main criterion for the inclusion of any product is that the product is the subject of an application with an effective approval that has not been withdrawn for safety or efficacy reasons. Contains therapeutic equivalence evaluations for approved multisource prescription drug products.

Approved Drug Products with Therapeutic Equivalence Evaluations, 1999

Approved Drug Products with Therapeutic Equivalence Evaluations, 1999 PDF Author: Barry Leonard
Publisher: DIANE Publishing
ISBN: 0788186795
Category :
Languages : en
Pages : 892

Book Description
Identifies drug products approved on the basis of safety & effectiveness by the FDA under the Federal Food, Drug, & Cosmetic Act. Drugs on the market approved only on the basis of safety (covered by the ongoing Drug Efficacy Study Implementation review) or pre-1938 drugs are not included in this publication. The main criterion for the inclusion of any product is that the product is the subject of an application with an effective approval that has not been withdrawn for safety or efficacy reasons. Contains therapeutic equivalence evaluations for approved multisource prescription drug products.

Approved Drug Products with Therapeutic Equivalence Evaluations

Approved Drug Products with Therapeutic Equivalence Evaluations PDF Author:
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 1048

Book Description


Approved Drug Products with Therapeutic Equivalence Evaluations - FDA Orange Book 31st Edition (2011)

Approved Drug Products with Therapeutic Equivalence Evaluations - FDA Orange Book 31st Edition (2011) PDF Author: Food and Drug Administration
Publisher: DrugPatentWatch.com
ISBN: 193489981X
Category : Medical
Languages : en
Pages : 1253

Book Description
FDA Orange Book 31st Edition - 2011 (Approved Drug Products With Therapeutic Equivalence Evaluations)

Approved Drug Products with Therapeutic Equivalence Evaluations - FDA Orange Book 32nd Edition (2012)

Approved Drug Products with Therapeutic Equivalence Evaluations - FDA Orange Book 32nd Edition (2012) PDF Author: Food and Drug Administration
Publisher: DrugPatentWatch.com
ISBN: 1934899828
Category : Medical
Languages : en
Pages : 1299

Book Description
FDA Orange Book 32nd Edition - 2012 (Approved Drug Products With Therapeutic Equivalence Evaluations)

Approved Drug Products with Therapeutic Equivalence Evaluations - FDA Orange Book 28th Edition (2008)

Approved Drug Products with Therapeutic Equivalence Evaluations - FDA Orange Book 28th Edition (2008) PDF Author: Food and Drug Administration
Publisher: DrugPatentWatch.com
ISBN: 193489978X
Category : Medical
Languages : en
Pages : 1103

Book Description
FDA Orange Book 28th Edition - 2008 (Approved Drug Products With Therapeutic Equivalence Evaluations)

Approved Drug Products with Therapeutic Equivalence Evaluations - FDA Orange Book 30th Edition (2010)

Approved Drug Products with Therapeutic Equivalence Evaluations - FDA Orange Book 30th Edition (2010) PDF Author: Food and Drug Administration
Publisher: DrugPatentWatch.com
ISBN: 1934899801
Category : Medical
Languages : en
Pages : 1115

Book Description
FDA Orange Book 30th Edition - 2010 (Approved Drug Products With Therapeutic Equivalence Evaluations)

Approved Drug Products with Therapeutic Equivalence Evaluations - FDA Orange Book 29th Edition (2009)

Approved Drug Products with Therapeutic Equivalence Evaluations - FDA Orange Book 29th Edition (2009) PDF Author: Food and Drug Administration
Publisher: DrugPatentWatch.com
ISBN: 1934899798
Category : Medical
Languages : en
Pages : 1161

Book Description
FDA Orange Book 29th Edition - 2009 (Approved Drug Products With Therapeutic Equivalence Evaluations)

MOVIPREP Drug Profile, 2023

MOVIPREP Drug Profile, 2023 PDF Author: DrugPatentWatch
Publisher: DrugPatentWatch.com
ISBN: 1934899836
Category : Medical
Languages : en
Pages : 101

Book Description

MOVIPREP Drug Profile, 2023

This report focuses on MOVIPREP and covers the following critical aspects of this drug:

  • United States patents
  • FDA Paragraph IV patent challenges
  • District Court patent litigation
  • European supplementary protection certificates (SPCs)
  • Clinical trials
  • Drug prices
  • Annual sales revenues
  • Finished product suppliers


Approved Drug Products With Therapeutic Equivalence Evaluations - FDA Orange Book 25th Edition (2005)

Approved Drug Products With Therapeutic Equivalence Evaluations - FDA Orange Book 25th Edition (2005) PDF Author: Food and Drug Administration
Publisher: DrugPatentWatch.com
ISBN: 1934899755
Category : Medical
Languages : en
Pages : 1039

Book Description
FDA Orange Book 25th Edition - 2005 (Approved Drug Products With Therapeutic Equivalence Evaluations)

NESINA Drug Profile, 2023

NESINA Drug Profile, 2023 PDF Author: DrugPatentWatch
Publisher: DrugPatentWatch.com
ISBN: 1934899852
Category : Medical
Languages : en
Pages : 100

Book Description

NESINA Drug Profile, 2023

This report focuses on NESINA and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • FDA Paragraph IV patent challenges
  • District Court patent litigation
  • European supplementary protection certificates (SPCs)
  • Clinical trials
  • Drug prices
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources